Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy-related persistent indirect hyperbilirubinemia

M Inbar1, O Merimsky, S Chaitchik

  • 1Department of Oncology, Tel-Aviv Sourasky Medical Center, Israel.

Anti-Cancer Drugs
|December 1, 1994
PubMed
Summary

Chemotherapy for testicular and breast cancers can cause long-term side effects. Two patients developed persistent indirect hyperbilirubinemia months after treatment, with the cause remaining unknown.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular analysis of feces reveals gastrointestinal nematodes in reintroduced wild asses of the Negev desert.

International journal for parasitology. Parasites and wildlife·2024
Same author

Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS).

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.

ESMO open·2021

Area of Science:

  • Oncology
  • Hepatology
  • Clinical Toxicology

Background:

  • Chemotherapy offers improved outcomes for testicular and breast cancers.
  • Adjuvant chemotherapy is used for both node-negative and node-positive breast cancer patients.
  • Chemotherapy regimens can lead to various early and late toxicities.

Observation:

  • Two cancer patients (breast and testicular) developed persistent asymptomatic indirect hyperbilirubinemia.
  • This condition was noted 3 and 14 months after chemotherapy cessation.
  • Metastatic liver disease and other causes of hyperbilirubinemia were ruled out.

Findings:

  • Chemotherapy regimens like cisplatin, vinblastine, and bleomycin (for testicular cancer) can cause cardiovascular, neurological, gastrointestinal, and renal issues.

Related Experiment Videos

  • Late effects of cyclophosphamide, methotrexate, and 5-fluorouracil (for breast cancer) may include obesity, amenorrhea, and infertility.
  • The exact etiology of the observed indirect hyperbilirubinemia post-chemotherapy remains undetermined.

    • Implications:

    • Highlights the potential for rare, delayed, and asymptomatic adverse effects of cancer chemotherapy.
    • Suggests the need for continued monitoring of liver function in cancer survivors post-chemotherapy.
    • Underscores the importance of investigating unexplained laboratory abnormalities in patients with a history of chemotherapy.